Light-triggered release of lenalidomide with fluorescent indication for inhibition of COX-2 enzyme activity in cancer cells

Ming Liu, Yajing Li, Fang Wang, Sheng Lu, Long Jiang, Xiaoqiang Chen

Research output: Contribution to journalArticlepeer-review

Abstract

In this work, we have developed a Sanger's reagent-based photocage, LNDA-NBD-Sanger, which releases the caged COX-2 inhibitor, lenalidomide (LNDA), under 400 nm UV irradiation while producing a fluorescent signal from the activated nitrobenzoxadiazole (NBD) derivative, realizing the monitoring of LNDA release in cancer cells and light-controlled anti-cancer therapy.

Original languageEnglish
Pages (from-to)6518-6521
Number of pages4
JournalChemical Communications
Volume61
Issue number35
DOIs
StatePublished - 28 Mar 2025

Fingerprint

Dive into the research topics of 'Light-triggered release of lenalidomide with fluorescent indication for inhibition of COX-2 enzyme activity in cancer cells'. Together they form a unique fingerprint.

Cite this